Development and clinical validation of a quantitative mass spectrometric assay for immuno-oncology targets in FFPE samples

被引：0
|
作者：
Thyparambil, Sheeno P. [1 ]
Cecchi, Fabiola [1 ]
An, Eunkyung [1 ]
Liao, Wei-Li [1 ]
Burrows, Jon [1 ]
Hembrough, Todd [1 ]
Catenacci, Daniel [2 ]
机构：
[1] Oncoplex Diagnost, Rockville, MD USA
[2] Univ Chicago Med, Chicago, MD USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-4255
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4255
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Development and clinical validation of a quantitative mass spectrometric assay for PD-L1 protein in FFPE NSCLC samples
    An, E.
    Liao, W.
    Thyparambil, S.
    Rodriguez, J.
    Salgia, R.
    Wistuba, I.
    Burrows, J.
    Hembrough, T.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 159 - 159
  • [2] Development and clinical validation of a quantitative mass spectrometric assay for PD-L1 protein in FFPE NSCLC samples.
    An, Eunkyung
    Liao, Wei-Li
    Thyparambil, Sheeno
    Rodriguez, Jaime
    Salgia, Ravi
    Wistuba, Ignacio I.
    Burrows, Jon
    Hembrough, Todd
    CLINICAL CANCER RESEARCH, 2014, 20
  • [3] Validation of digital spatial profiling of key immuno-oncology targets for mouse FFPE preclinical models
    Warren, Sarah
    Metz, Heather
    Barker, Kristi
    Gong, JingJing
    VanSchoiack, Alison
    Quoc Huynh
    Merritt, Chris
    Dennis, Lucas
    Liang, Yan
    Beechem, Joseph M.
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Development and validation of a screening platform for the identification of novel immuno-oncology targets
    Scoumanne, Ariane
    Rabolli, Virginie
    Legrand, Lea
    Martini, Murielle
    Letellier, Marie-Claire
    Crosignani, Stefano
    Queva, Christophe
    Detheux, Michel
    Cauwenberghs, Sandra
    Swiercz, Jakub
    CANCER RESEARCH, 2017, 77
  • [5] Gene expression measurement of immuno-oncology targets in a single FFPE section using a novel targeted sequencing assay
    Reinholz, Monica M.
    Thompson, Debrah
    Cooley, James
    Chen, Xiao-Bo
    Howlett, Iris
    Luecke, John
    Roche, Patrick
    LaFleur, Bonnie
    CANCER RESEARCH, 2016, 76
  • [6] Development and validation of a phenotypic screening platform for the identification of novel immuno-oncology targets
    Rabolli, Virginie
    Martini, Murielle
    Scoumanne, Ariane
    Letellier, Marie-Claire
    Crosignani, Stefano
    Queva, Christophe
    Detheux, Michel
    Swiercz, Jakub M.
    Cauwenberghs, Sandra
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [7] Clinical development of immuno-oncology therapeutics
    Wang, Jianxin
    Chen, Qi
    Shan, Qiang
    Liang, Tingbo
    Forde, Patrick
    Zheng, Lei
    CANCER LETTERS, 2025, 617
  • [8] Clinical development of immuno-oncology in China
    Wu, Da-Wei
    Huang, Hui-Yao
    Tang, Yu
    Zhao, Yang
    Yang, Zhi-Min
    Wang, Jun
    Wang, Shu-Hang
    Yu, Yue
    Fang, Yuan
    Fang, Hong
    Bai, Ying
    Sun, Chao
    Fan, Qi
    Yu, An-Qi
    Wang, Huan-Ling
    Du, Chun-Xia
    Chen, Kun
    Huang, Ming-De
    Zhang, Yin
    Li, Ning
    Xu, Bing-He
    Sun, Yan
    He, Jie
    LANCET ONCOLOGY, 2020, 21 (08): : 1013 - 1016
  • [9] Quantitative Translation in Immuno-Oncology Research and Development
    Bottino, Dean
    Liu, Rachael
    Bazzazi, Hojjat
    Venkatakrishnan, Karthik
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (03) : 430 - 433
  • [10] Computational discovery and experimental validation of novel drug targets in immuno-oncology
    Machlenkin, Arthur
    Levy, Ofer
    Rotman, Galit
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
12345